ChitogenX Inc. ( CHNXF) - Key Metrics
CHNXF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q3 | $0 | -$0.01 | $0 | $0 |
| 2025Q2 | $0 | $0 | $0 | $0 |
| 2025Q1 | $0 | $0 | $0 | $0 |
| 2024Q4 | $0 | -$0.01 | $0 | $0 |
| 2024Q3 | $0 | -$0.01 | $0 | $0 |
CHNXF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q3 | 0% | -0.25 |
| 2025Q2 | 0% | -1.20 |
| 2025Q1 | 0% | -6.42 |
| 2024Q4 | 0% | -3.85 |
| 2024Q3 | 0% | -2.23 |
CHNXF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q3 | 5.98% | 0% |
| 2025Q2 | -1.57% | 0% |
| 2025Q1 | -1.80% | 0% |
| 2024Q4 | -1.29% | 0% |
| 2024Q3 | -4.21% | 0% |
CHNXF
Price: $0.01
52 week price:
Earnings Per Share: -0.01 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 627627